LACEY MARTIN: Open Payments
NPI 1639887011 · CASPER, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,436 in 69 payments from 16 companies in 2025. Trend: 2023 $869 · 2024 $1,130 · 2025 $1,436
Food & beverage: $1,436
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $350 |
| ABBVIE INC. | 19 | $342 |
| Janssen Biotech, Inc. | 10 | $192 |
| Madrigal Pharmaceuticals | 4 | $100 |
| Gilead Sciences, Inc. | 4 | $81 |
| GENZYME CORPORATION | 4 | $79 |
| PFIZER INC. | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Intercept Pharmaceuticals, Inc. | 2 | $37 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
Products named: ENTYVIO, TREMFYA, LINZESS, DUPIXENT, EOHILIA, REZDIFFRA, RINVOQ, SKYRIZI.
Industry payments across WY — which companies pay providers there.
